• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[中东呼吸综合征冠状病毒重组疫苗的新研究进展]

[Novel Research Progress of the Recombinant Vaccine for MERS-CoV].

作者信息

Hu Huizhen, Shen Yuqing

出版信息

Bing Du Xue Bao. 2016 Jul;32(4):495-500.

PMID:29995374
Abstract

Respiratory syndrome coronavirus in the Middle East (MERS-Co V) has caused wide attention since it was discovered, and the design of effective vaccines for MERS-Co V becomes a hot area at present. Therefore, this review is aimed at novel research progress of the recombinant vaccine for MERS-Co V, including selection and improvement of animal model for vaccine test,construction and optimization of recombinant subunit vaccine, attempts at recombinant live vector vaccine based on varies of vectors, as well as the advantages of pseudovirus. In conclusion, we make a summary about the novel research progress of the recombinant vaccine for MERS-Co V and a promising prospect of its development in terms of both safety and effectiveness verification in the future will be demonstrated.

摘要

中东呼吸综合征冠状病毒(MERS-CoV)自被发现以来引起了广泛关注,目前针对MERS-CoV的有效疫苗设计成为一个热门领域。因此,本综述旨在探讨MERS-CoV重组疫苗的最新研究进展,包括疫苗试验动物模型的选择与改进、重组亚单位疫苗的构建与优化、基于多种载体的重组活载体疫苗的尝试以及假病毒的优势。总之,我们对MERS-CoV重组疫苗的最新研究进展进行了总结,并展示了其在未来安全性和有效性验证方面发展的广阔前景。

相似文献

1
[Novel Research Progress of the Recombinant Vaccine for MERS-CoV].[中东呼吸综合征冠状病毒重组疫苗的新研究进展]
Bing Du Xue Bao. 2016 Jul;32(4):495-500.
2
The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.刺突蛋白的重组N端结构域是一种预防中东呼吸综合征冠状病毒(MERS-CoV)感染的潜在疫苗。
Vaccine. 2017 Jan 3;35(1):10-18. doi: 10.1016/j.vaccine.2016.11.064. Epub 2016 Nov 26.
3
MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.中东呼吸综合征冠状病毒刺突纳米颗粒可保护小鼠免受中东呼吸综合征冠状病毒感染。
Vaccine. 2017 Mar 14;35(12):1586-1589. doi: 10.1016/j.vaccine.2017.02.012. Epub 2017 Feb 23.
4
A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model.一种基于腺病毒的高度免疫原性、保护性和安全性疫苗,在转基因人二肽基肽酶 4 小鼠模型中表达中东呼吸综合征冠状病毒 S1-CD40L 融合蛋白。
J Infect Dis. 2019 Oct 8;220(10):1558-1567. doi: 10.1093/infdis/jiz137.
5
Antibodies and vaccines against Middle East respiratory syndrome coronavirus.抗中东呼吸综合征冠状病毒的抗体和疫苗。
Emerg Microbes Infect. 2019;8(1):841-856. doi: 10.1080/22221751.2019.1624482.
6
Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice.基于重组复制缺陷型狂犬病病毒的二价疫苗(针对 MERS-CoV 和狂犬病病毒)的研制及其在小鼠体内的体液免疫原性。
PLoS One. 2019 Oct 7;14(10):e0223684. doi: 10.1371/journal.pone.0223684. eCollection 2019.
7
DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice.编码中东呼吸综合征冠状病毒S1蛋白的DNA疫苗在小鼠中诱导保护性免疫反应。
Vaccine. 2017 Apr 11;35(16):2069-2075. doi: 10.1016/j.vaccine.2017.02.063. Epub 2017 Mar 14.
8
A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.一种基于重组麻疹病毒疫苗平台的高免疫原性和保护性中东呼吸综合征冠状病毒疫苗。
J Virol. 2015 Nov;89(22):11654-67. doi: 10.1128/JVI.01815-15. Epub 2015 Sep 9.
9
Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice.两种不同载体的中东呼吸综合征冠状病毒候选疫苗在小鼠中的免疫反应特征。
Viruses. 2020 Jan 20;12(1):125. doi: 10.3390/v12010125.
10
[Current Status of Middle East Respiratory Syndrome Vaccines].[中东呼吸综合征疫苗的现状]
Bing Du Xue Bao. 2016 Nov;32(6):825-9.